130 related articles for article (PubMed ID: 15581187)
21. Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies.
Bernardi R; Pandolfi PP
Nat Rev Mol Cell Biol; 2007 Dec; 8(12):1006-16. PubMed ID: 17928811
[TBL] [Abstract][Full Text] [Related]
22. Stabilization of PML nuclear localization by conjugation and oligomerization of SUMO-3.
Fu C; Ahmed K; Ding H; Ding X; Lan J; Yang Z; Miao Y; Zhu Y; Shi Y; Zhu J; Huang H; Yao X
Oncogene; 2005 Aug; 24(35):5401-13. PubMed ID: 15940266
[TBL] [Abstract][Full Text] [Related]
23. Preferential recruitment of ataxin-3 independent of expanded polyglutamine: an immunohistochemical study on Marinesco bodies.
Fujigasaki H; Uchihara T; Takahashi J; Matsushita H; Nakamura A; Koyano S; Iwabuchi K; Hirai S; Mizusawa H
J Neurol Neurosurg Psychiatry; 2001 Oct; 71(4):518-20. PubMed ID: 11561037
[TBL] [Abstract][Full Text] [Related]
24. Patient mutations alter ATRX targeting to PML nuclear bodies.
Bérubé NG; Healy J; Medina CF; Wu S; Hodgson T; Jagla M; Picketts DJ
Eur J Hum Genet; 2008 Feb; 16(2):192-201. PubMed ID: 17957225
[TBL] [Abstract][Full Text] [Related]
25. A nucleolar targeting signal in PML-I addresses PML to nucleolar caps in stressed or senescent cells.
Condemine W; Takahashi Y; Le Bras M; de Thé H
J Cell Sci; 2007 Sep; 120(Pt 18):3219-27. PubMed ID: 17878236
[TBL] [Abstract][Full Text] [Related]
26. The Spatial Organization of the Intranuclear Structures of Human Brain Dopaminergic Neurons.
Korzhevskii DE; Gusel'nikova VV; Kirik OV; Sukhorukova EG; Grigorev IP
Acta Naturae; 2017; 9(3):81-88. PubMed ID: 29104779
[TBL] [Abstract][Full Text] [Related]
27. Intranuclear ubiquitin immunoreactivity of the pigmented neurons of the substantia nigra in fatal acute mechanical asphyxiation and drowning.
Quan L; Zhu BL; Ishida K; Oritani S; Taniguchi M; Fujita MQ; Maeda H
Int J Legal Med; 2001 Aug; 115(1):6-11. PubMed ID: 11599772
[TBL] [Abstract][Full Text] [Related]
28. Neuronal intranuclear inclusion disease: neuropathologic study of a case.
Malandrini A; Villanova M; Tripodi S; Palmeri S; Sicurelli F; Parrotta E; Berti G; Salvadori C; Cintorino M; Guazzi GC
Brain Dev; 1998 Aug; 20(5):290-4. PubMed ID: 9760997
[TBL] [Abstract][Full Text] [Related]
29. PML bodies: a meeting place for genomic loci?
Ching RW; Dellaire G; Eskiw CH; Bazett-Jones DP
J Cell Sci; 2005 Mar; 118(Pt 5):847-54. PubMed ID: 15731002
[TBL] [Abstract][Full Text] [Related]
30. Intranuclear aggregation of nonexpanded ataxin-3 in marinesco bodies of the nonhuman primate substantia nigra.
Kettner M; Willwohl D; Hubbard GB; Rüb U; Dick EJ; Cox AB; Trottier Y; Auburger G; Braak H; Schultz C
Exp Neurol; 2002 Jul; 176(1):117-21. PubMed ID: 12093088
[TBL] [Abstract][Full Text] [Related]
31. Comparison of the SUMO1 and ubiquitin conjugation pathways during the inhibition of proteasome activity with evidence of SUMO1 recycling.
Bailey D; O'Hare P
Biochem J; 2005 Dec; 392(Pt 2):271-81. PubMed ID: 16117725
[TBL] [Abstract][Full Text] [Related]
32. A novel GTPase, CRAG, mediates promyelocytic leukemia protein-associated nuclear body formation and degradation of expanded polyglutamine protein.
Qin Q; Inatome R; Hotta A; Kojima M; Yamamura H; Hirai H; Yoshizawa T; Tanaka H; Fukami K; Yanagi S
J Cell Biol; 2006 Feb; 172(4):497-504. PubMed ID: 16461359
[TBL] [Abstract][Full Text] [Related]
33. Role of the promyelocytic leukemia body in the dynamic interaction between the androgen receptor and steroid receptor coactivator-1 in living cells.
Rivera OJ; Song CS; Centonze VE; Lechleiter JD; Chatterjee B; Roy AK
Mol Endocrinol; 2003 Jan; 17(1):128-40. PubMed ID: 12511612
[TBL] [Abstract][Full Text] [Related]
34. SCANning for PML nuclear bodies with Myeloid Zinc Finger 1.
Gallagher RE
Leuk Res; 2008 Nov; 32(11):1650-2. PubMed ID: 18586322
[No Abstract] [Full Text] [Related]
35. The number of PML nuclear bodies increases in early S phase by a fission mechanism.
Dellaire G; Ching RW; Dehghani H; Ren Y; Bazett-Jones DP
J Cell Sci; 2006 Mar; 119(Pt 6):1026-33. PubMed ID: 16492708
[TBL] [Abstract][Full Text] [Related]
36. The ND10 component promyelocytic leukemia protein relocates to human papillomavirus type 1 E4 intranuclear inclusion bodies in cultured keratinocytes and in warts.
Roberts S; Hillman ML; Knight GL; Gallimore PH
J Virol; 2003 Jan; 77(1):673-84. PubMed ID: 12477870
[TBL] [Abstract][Full Text] [Related]
37. Nucleus accumbens associated 1 is recruited within the promyelocytic leukemia nuclear body through SUMO modification.
Tatemichi Y; Shibazaki M; Yasuhira S; Kasai S; Tada H; Oikawa H; Suzuki Y; Takikawa Y; Masuda T; Maesawa C
Cancer Sci; 2015 Jul; 106(7):848-56. PubMed ID: 25891951
[TBL] [Abstract][Full Text] [Related]
38. G protein-coupled receptor 26 immunoreactivity in intranuclear inclusions associated with polyglutamine and intranuclear inclusion body diseases.
Mori F; Tanji K; Miki Y; Toyoshima Y; Yoshida M; Kakita A; Takahashi H; Utsumi J; Sasaki H; Wakabayashi K
Neuropathology; 2016 Feb; 36(1):50-5. PubMed ID: 26303144
[TBL] [Abstract][Full Text] [Related]
39. Promyelocytic leukemia (PML) nuclear bodies are disorganized in colorectal tumors with total loss of major histocompatibility complex class I expression and LMP7 downregulation.
Cabrera CM; Jiménez P; Concha A; Garrido F; Ruiz-Cabello F
Tissue Antigens; 2004 May; 63(5):446-52. PubMed ID: 15104675
[TBL] [Abstract][Full Text] [Related]
40. Stress responses of PML nuclear domains are ablated by ataxin-1 and other nucleoprotein inclusions.
Dovey CL; Varadaraj A; Wyllie AH; Rich T
J Pathol; 2004 Aug; 203(4):877-83. PubMed ID: 15258989
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
